Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in creating active pharmaceutical ingredients (APIs) due to its nitrogen-containing heterocyclic structure, which can enhance binding to biological targets. Commonly employed in research settings for drug discovery programs focusing on oncology and inflammatory diseases. Also utilized in the preparation of pyridine-based ligands for catalysis in organic synthesis.